Literature DB >> 3926569

Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. Origin and design of the Kroc Collaborative Study.

M C Champion, H Keen, J C Pickup, W V Tamborlane, J Dupre.   

Abstract

Although the benefits of metabolic intervention on the microvascular complications of diabetes mellitus remain unproven, it is generally assumed though not proven that prognosis in terms of blindness and renal failure will reflect the long-term glycemic response to therapy. Treatment goals however remain poorly defined. Costs and hazards of achieving near-normoglycemia in insulin-dependent diabetes mellitus (IDDM) are major. A multicenter trial was proposed to test the hypothesis that in IDDM two levels of mean glycemia, sufficiently separated to examine the control/complications relationship, could be maintained by the six collaborating centers, using randomized patient allocation to conventional insulin therapy (CIT) and continuous subcutaneous insulin infusion (CSII) as the alternative treatment modalities. Methods of maintaining and monitoring metabolic control and of assessing renal and retinal responses were to be applied, evaluated, and possibly improved. All clinics shared a common experimental protocol, which received ethical approval at each treatment center. Retinal assessment facilities were provided by the Fundus Photograph Reading Center at the University of Wisconsin in Madison, and at the Diabetic Retinopathy Department, Royal Postgraduate Medical School, Hammersmith, United Kingdom. The Central Biochemistry Laboratory was at the University of Newcastle, United Kingdom. Collaborators agreed on policy for recruitment, baseline assessment, and randomization of patients with IDDM, complicated by early microvascular disease. CIT took the form of the unchanged prestudy regimen; glycemic goals were set for CSII and their achievement based on inpatient and outpatient sampling of plasma glucose. Glycosylated hemoglobin was measured, retinal abnormalities recorded photographically, and urinary albumin excretion quantitated at baseline, 4, and 8 mo in all patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 3926569     DOI: 10.2337/diab.34.3.s5

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  5 in total

1.  The interaction between the adenylate cyclase system and insulin-stimulated glucose transport. Evidence for the importance of both cyclic-AMP-dependent and -independent mechanisms.

Authors:  P Lönnroth; J I Davies; I Lönnroth; U Smith
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

2.  Is insulin-dependent diabetes mellitus an autoimmune disorder?

Authors:  M H Tan; R McManus
Journal:  Can Fam Physician       Date:  1987-02       Impact factor: 3.275

3.  Anomeric specificity of hexokinase and glucokinase activities in liver and insulin-producing cells.

Authors:  A Sener; M H Giroix; S P Dufrane; W J Malaisse
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

4.  Phorbol esters imitate in rat fat-cells the full effect of insulin on glucose-carrier translocation, but not on 3-O-methylglucose-transport activity.

Authors:  C Mühlbacher; E Karnieli; P Schaff; B Obermaier; J Mushack; E Rattenhuber; H U Häring
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

Review 5.  Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.

Authors:  Pernille Kähler; Berit Grevstad; Thomas Almdal; Christian Gluud; Jørn Wetterslev; Søren Søgaard Lund; Allan Vaag; Bianca Hemmingsen
Journal:  BMJ Open       Date:  2014-08-19       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.